6420399

2 known cases. View patent page →

Cases
2
Active
0
2 closed
Filed
2008
Top venue
D. New Jersey
2 cases

Celgene Corporation et al. v. Barr Laboratories, Inc.

dismissed
Docket:
2:08-cv-03357
Filed:
2008-07-03
Terminated:
2010-05-21

Action identified as one of six district-court actions relating to the '501 patent, consolidated with the Barr actions and dismissed without prejudice on May 21, 2010. Whether the '018 patent was separately asserted in this action is unconfirmed.

In re Thalomid and Revlimid Purchaser Antitrust Litigation

consolidated
Docket:
2:14-cv-06997

Consolidated purchaser/insurer antitrust litigation alleging Celgene improperly listed Thalomid/Revlimid distribution-method patents in the Orange Book and pursued sham litigation. The '018 patent is referenced within the distribution-method patent family but is not asserted for infringement.